NR1H4 and diabetic kidney disease: Experimental studies have revealed that simvastatin ameliorates renal pathology by activating the farnesoid X receptor and Nrf2/HO-1 signaling axis, thereby attenuating oxidative damage, inflammatory responses, and apoptotic pathways in DKD [165].